AusPAR: Regorafenib

Australian Public Assessment Report

AusPAR

AusPAR: Regorafenib [PDF, 1.1 MB]

AusPAR: Regorafenib [Word, 1.15 MB]

Attachment: Product Information: Regorafenib [PDF, 455.57 KB]

Attachment: Product Information: Regorafenib [Word, 698.07 KB]

Attachment: Extract from Clinical Evaluation Report: Regorafenib [PDF, 1.48 MB]

Attachment: Extract from Clinical Evaluation Report: Regorafenib [Word, 1.87 MB]

Device/Product Name

Stivarga

Active ingredients

Regorafenib

AusPAR Date

19 November 2015

Published

25 November 2015

Submission Number

PM-2013-04954-1-4

Submission Type

Extension of indications

Decision

Approved